Endothelial cell senescence and thrombosis: Ageing clots

Area of Science:

• Cardiovascular Research
• Aging Biology
• Endothelial Cell Biology

Background:

• Aging is a major cardiovascular risk factor, increasing thrombotic complications beyond traditional risk factors.
• Endothelial cell senescence, characterized by specific functional alterations, is implicated in cardiovascular disease development.
• Impaired endothelial repair mechanisms and altered thrombosis/fibrinolysis contribute to age-related vascular issues.

Purpose of the Study:

• To review the impact of aging on endothelial cell morphology and function.
• To discuss the role of endothelial senescence in age-related thrombotic events.
• To explore mechanisms, models, and potential therapeutic targets for endothelial senescence.

Main Methods:

• Review of existing clinical and experimental studies (rodent and other models).
• Analysis of findings on endothelial cell senescence-associated secretory phenotype.
• Examination of altered expression of factors involved in thrombosis and fibrinolysis.

Main Results:

• Aging alters endothelial cell morphology and function, including senescence-associated secretory phenotype.
• Endothelial senescence is linked to impaired vascular repair and increased thrombotic risk.
• Studies in various models suggest a connection between endothelial senescence and thrombotic events.

Conclusions:

• Endothelial cell senescence plays a significant role in age-related cardiovascular thrombotic complications.
• Understanding the mechanisms of endothelial senescence can guide the development of targeted therapies.
• Interventions aimed at preventing or treating endothelial senescence may reduce the burden of age-associated thrombosis.